DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactEarnings

OBSC Perfection Limited — Outcome of Board Meeting

NSE 58 min ago·11 Sept 2026, 9:17 am

Obsc Perfection

OBSC Perfection Limited has informed stock exchanges that its board approved the allotment of shares on September 11, 2026. This corporate action typically occurs when a company issues new equity to raise capital, such as through a rights issue, private placement, or employee stock option plan. The allotment process finalizes the issuance of these new shares to the respective shareholders or entities.

For investors, this announcement signals a potential dilution of existing ownership stakes, as the total number of shares in the company will increase. While this can affect the earnings per share and market value of existing holdings, it also indicates that the company is seeking funds to fuel its growth or meet specific financial obligations. Investors should monitor the purpose of the fundraise to gauge its impact on the company's future prospects.